Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Hematology

Does Glanzmann Thrombasthenia Shorten Life Expectancy?

At a Glance

Glanzmann Thrombasthenia does not inherently shorten life expectancy. With proper care from a Hemophilia Treatment Center and a proactive emergency bleeding plan, patients can live long, normal lives. The primary risk is severe bleeding, which is safely managed with modern medical therapies.

In this answer

2 sections

01

Why the Prognosis is Positive Today

02

Living a “Normal” Life with GT

When you or your child are first diagnosed with a rare disease, the first question is usually the scariest: Will this shorten their life? The reassuring truth is that Glanzmann Thrombasthenia (GT) is not a progressive or terminal illness, and it does not inherently shorten a person’s lifespan [1][2]. In regions with access to modern medical care, people with GT can expect to live long, fulfilling, and normal lives [3][4].

Because GT is a bleeding disorder, the primary risk to life comes from severe hemorrhage rather than a worsening of the condition itself [1][2]. Fortunately, advancements in medical treatments have made these bleeding risks highly manageable [5][6].

Why the Prognosis is Positive Today

Historically, severe bleeding disorders carried much higher risks. Today, a combination of specialized care and modern medical therapies has dramatically changed the outlook for patients with GT:

  • Managing Minor Bleeds: For day-to-day management of mucosal bleeds (like stubborn nosebleeds or heavy menstrual bleeding), doctors often use anti-fibrinolytic medications. These help stabilize blood clots once they form. Menstruation, a major challenge for women with GT, is also frequently managed proactively with hormonal therapies (like birth control) and close obstetric monitoring [7][8].
  • Handling Major Bleeding: Acute severe bleeding episodes and surgical procedures are typically managed using platelet transfusions or medications like recombinant activated factor VII (rFVIIa) [9][2]. Because patients can develop antibodies (an immune response) to transfused platelets over time from frequent transfusions, future transfusions can become less effective. rFVIIa helps blood clot even if this immune response has developed, making it a safe and crucial alternative [3][10].
  • Curative Options for Severe Cases: In rare, highly severe cases where patients experience constant, life-threatening bleeds despite all medication, a hematopoietic stem cell transplant (HSCT)—often called a bone marrow transplant—may be considered [11][12]. While this can completely correct the underlying platelet defect, it carries profound, life-threatening risks (such as graft-versus-host disease) and is typically reserved only for patients whose bleeding cannot be safely controlled otherwise [13].

Living a “Normal” Life with GT

While GT does not reduce life expectancy, it does require a lifetime of proactive management. The frequent need to manage bleeding events can create physical and emotional burdens, which can impact your overall quality of life if not properly supported [14][15]. Living well with GT means making adaptations rather than giving up on your goals.

To ensure a long, healthy life, care should focus on:

1. Connecting with a Hemophilia Treatment Center (HTC)

The single most important step you can take is to establish care with a specialized center [16][5]. HTCs provide comprehensive, multidisciplinary care teams—including hematologists, specialized nurses, social workers, and physical therapists—who understand rare bleeding disorders. They coordinate complex care needs, such as planning for dental work, managing heavy periods, or preparing for major life events.

2. Creating an Emergency Preparedness Plan

Because regular doctors and emergency rooms may have never encountered GT, you must be your own advocate. You should carry a personalized, written emergency bleeding protocol—often called an ER Card or treatment letter—provided by your hematologist [17][4]. This ensures that if a severe bleed occurs, emergency personnel know exactly what treatments to administer without delay [6].

3. Avoiding Dangerous Medications

Do not take aspirin or NSAIDs (like ibuprofen, naproxen, or Advil). These common over-the-counter pain relievers further inhibit platelet function and can trigger dangerous bleeding episodes. Always clear any new medication, supplement, or herbal remedy with your hematology team before taking it.

4. Monitoring Secondary Health Impacts

Frequent minor or severe bleeds can lead to secondary health issues, most notably iron deficiency anemia, which can cause extreme fatigue and, in children, impact growth [18][19]. Regular monitoring of your iron levels and proactive supplementation when necessary are critical parts of long-term care [14].

With the right medical team, a proactive emergency plan, and a focus on daily management, a diagnosis of Glanzmann Thrombasthenia is a condition you manage, not one that dictates your life expectancy.

Common questions in this guide

Do Glanzmann Thrombasthenia Carriers Have Bleeding Symptoms?Does Type 1 Glanzmann Thrombasthenia Mean Worse Bleeding?How Does Glanzmann Thrombasthenia Differ From HemophiliaHow Rare is Glanzmann Thrombasthenia? Prevalence & FactsHow to Stop Severe Nosebleeds with GTWill I Pass Glanzmann Thrombasthenia to My Baby?Is There a Cure for Glanzmann Thrombasthenia? ExplainedHow to Manage Heavy Periods with Glanzmann ThrombastheniaCan You Have a Baby With Glanzmann Thrombasthenia?What Sports Are Safe for Glanzmann Thrombasthenia?What to Include in a GT Emergency LetterWhy Avoid NSAIDs With Glanzmann Thrombasthenia?Why Avoid Platelet Transfusions in GT?Why Do Blood Tests Miss Glanzmann Thrombasthenia?How to Manage Dental Surgery with Glanzmann Thrombasthenia
Does Glanzmann Thrombasthenia shorten your life expectancy?
No, Glanzmann Thrombasthenia is not a terminal illness and does not inherently shorten lifespan. With access to modern medical care and proper bleeding management, patients can expect to live long, normal, and fulfilling lives.
What are the main life-threatening risks of Glanzmann Thrombasthenia?
The primary risk to life is severe, uncontrolled hemorrhage. Because the condition itself is not progressive, effectively managing severe bleeding episodes with an emergency protocol and specialized care is the key to long-term safety.
Why do patients with Glanzmann Thrombasthenia need to avoid ibuprofen and aspirin?
Medications like aspirin and NSAIDs, such as ibuprofen or naproxen, further inhibit platelet function. Taking these common pain relievers can trigger dangerous and potentially life-threatening bleeding episodes in people with this condition.
What is an ER card for bleeding disorders?
An ER card is a personalized, written emergency bleeding protocol provided by your hematologist. Because many emergency rooms may not be familiar with this rare condition, the card tells doctors exactly what life-saving treatments to administer quickly.
How is heavy menstrual bleeding managed in Glanzmann Thrombasthenia?
Menstruation is often managed proactively using anti-fibrinolytic medications to help stabilize blood clots, along with hormonal therapies like birth control. Close monitoring by both a gynecologist and hematologist is essential to prevent excessive blood loss.

Questions for Your Doctor

5 questions

  • •What is the process for getting a personalized 'ER Card' or written emergency protocol for myself or my child?
  • •At what point does a nosebleed, cut, or injury become an emergency that requires a trip to the ER rather than managing it at home?
  • •How frequently will we monitor my iron levels to catch anemia before it causes severe fatigue or impacts growth?
  • •What specific over-the-counter medications are safe to use for pain or fever, since I know I must avoid NSAIDs and aspirin?
  • •What proactive steps should we take to safely manage heavy menstrual bleeding before it becomes an emergency?

Questions for You

3 questions

  • •What activities or hobbies do I currently enjoy, and how might I need to adapt them to stay safe while still having fun?
  • •Have I fully communicated my medical needs and emergency protocol to my school, workplace, or close family members?
  • •Am I currently experiencing symptoms like extreme fatigue or weakness that could be signs of iron deficiency anemia?

References

References (19)
  1. 1

    One day at a time: Life with Glanzmann thrombasthenia - Qualitative results from the GT 360 study.

    Khair K, Fletcher S, Jenner K, Holland M

    Haemophilia : the official journal of the World Federation of Hemophilia 2024; (30(6)):1373-1382 doi:10.1111/hae.15126.

    PMID: 39545676
  2. 2

    The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention.

    Poon MC, d'Oiron R, Zotz RB, et al.

    Haematologica 2015; (100(8)):1038-44 doi:10.3324/haematol.2014.121384.

    PMID: 26001792
  3. 3

    The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.

    Di Minno G, Zotz RB, d'Oiron R, et al.

    Haematologica 2015; (100(8)):1031-7 doi:10.3324/haematol.2014.121475.

    PMID: 26001793
  4. 4

    Perioperative Hemostatic Management of a Pediatric Patient with Glanzmann Thrombasthenia Undergoing Osteoplastic Craniotomy and Hematoma Removal: A Case Report.

    Lee SM, Kim KN, Kim SY

    Acta haematologica 2019; (142(4)):244-248 doi:10.1159/000499362.

    PMID: 31085914
  5. 5

    Glanzmann Thrombasthenia: Perspectives from Clinical Practice on Accurate Diagnosis and Optimal Treatment Strategies.

    Mathews N, Rivard GE, Bonnefoy A

    Journal of blood medicine 2021; (12()):449-463 doi:10.2147/JBM.S271744.

    PMID: 34149292
  6. 6

    How we treat the platelet glycoprotein defects; Glanzmann thrombasthenia and Bernard Soulier syndrome in children and adults.

    Grainger JD, Thachil J, Will AM

    British journal of haematology 2018; (182(5)):621-632 doi:10.1111/bjh.15409.

    PMID: 30117143
  7. 7

    Ferric carboxymaltose for sub-acute and chronic iron deficiency anemia in inherited platelet function defects.

    Scaramellini N, Capecchi M, Artoni A, et al.

    Internal and emergency medicine 2021; (16(2)):505-507 doi:10.1007/s11739-020-02478-x.

    PMID: 32845453
  8. 8

    Obstetric and Gynaecological Challenges and Outcomes in Women and Girls With Glanzmann's Thrombasthenia.

    Obeng-Tuudah D, Tarawah A, Ozkan M, Abdul-Kadir R

    Haemophilia : the official journal of the World Federation of Hemophilia 2025; (31(3)):509-518 doi:10.1111/hae.70030.

    PMID: 40123272
  9. 9

    Efficacy and safety of recombinant activated factor VII in Glanzmann thrombasthenia: A systematic literature review.

    Saultier P, Grino M, Falaise C, et al.

    Haemophilia : the official journal of the World Federation of Hemophilia 2025; (31(1)):7-15 doi:10.1111/hae.15130.

    PMID: 39604156
  10. 10

    The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia.

    Poon MC

    Thrombosis and haemostasis 2021; (121(3)):332-340 doi:10.1055/s-0040-1718373.

    PMID: 33124022
  11. 11

    Excellent Outcome Following Sibling Peripheral Blood Hematopoietic Stem Cell Transplantation for Glanzmann Thrombasthenia: A Case Report.

    Li JH, Sun SW, Ai Y, et al.

    Frontiers in pediatrics 2021; (9()):776927 doi:10.3389/fped.2021.776927.

    PMID: 35198519
  12. 12

    Stem Cell Transplant in Severe Glanzmann Thrombasthenia in an Adult Patient.

    Ramzi M, Dehghani M, Haghighat S, Nejad HH

    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2016; (14(6)):688-690 doi:10.6002/ect.2014.0165.

    PMID: 26134714
  13. 13

    Successful Use of Hematopoietic Stem Cell Transplantation for 2 Pediatric Cases of Glanzmann Thrombasthenia and Review of the Literature.

    Friend BD, Roach GD, Kempert PH, Moore TB

    Journal of pediatric hematology/oncology 2020; (42(6)):e521-e526 doi:10.1097/MPH.0000000000001646.

    PMID: 31693514
  14. 14

    Bleeding and quality of life in people with Glanzmann thrombasthenia-insights from the Glanzmann's 360 study.

    Khair K, Fletcher S, Boyton M, Holland M

    Research and practice in thrombosis and haemostasis 2024; (8(7)):102586 doi:10.1016/j.rpth.2024.102586.

    PMID: 39526289
  15. 15

    Gene Therapy in Hemophilia: A Transformational Patient Experience.

    Rasul E, Hallock R, Hellmann M, et al.

    Journal of patient experience 2023; (10()):23743735231193573 doi:10.1177/23743735231193573.

    PMID: 37663068
  16. 16

    Perioperative Platelet Transfusion Strategies and Multidisciplinary Collaboration Experience in Glanzmann Thrombasthenia Caused by ITGA2B Gene Variation During Pregnancy: A Case Report.

    Cui X, Ji N, Wang S, et al.

    International journal of women's health 2025; (17()):4559-4564 doi:10.2147/IJWH.S548705.

    PMID: 41281951
  17. 17

    Emergency management of patients with Glanzmann thrombasthenia: consensus recommendations from the French reference center for inherited platelet disorders.

    Fiore M, Giraudet JS, Alessi MC, et al.

    Orphanet journal of rare diseases 2023; (18(1)):171 doi:10.1186/s13023-023-02787-2.

    PMID: 37386449
  18. 18

    Iron deficiency anemia and bleeding management in pediatric patients with Bernard-Soulier syndrome and Glanzmann Thrombasthenia: A single-institution analysis.

    Lee A, Maier CL, Batsuli G

    Haemophilia : the official journal of the World Federation of Hemophilia 2022; (28(4)):633-641 doi:10.1111/hae.14559.

    PMID: 35412688
  19. 19

    Glanzmann Thrombasthenia in Children: Experience From a Tertiary Care Center in Southern India.

    Kongalappa S, Reddy JM, Durugappa T, et al.

    Journal of pediatric hematology/oncology 2019; (41(2)):e68-e71 doi:10.1097/MPH.0000000000001367.

    PMID: 30789846

This page provides educational information about Glanzmann Thrombasthenia prognosis and life expectancy. Always consult your hematologist or Hemophilia Treatment Center for personalized medical advice and emergency planning.

Get notified when new evidence is published on Glanzmann Thrombasthenia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.